Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Breathe (Sheffield, England)|January 15, 2021
Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroidsChristopher J Brereton, Helen E JoDrugs & Aging|April 17, 2016
Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management ConsiderationsHelen E Jo, Sharan Randhawa, Tamera J Corte, et al.Heart, Lung & Circulation|March 15, 2017
Medical Therapy Versus Balloon Angioplasty for CTEPH: A Systematic Review and Meta-AnalysisKevin Phan, Helen E Jo, Joshua Xu, et al.BMC Pulmonary Medicine|February 3, 2016
Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centresHelen E Jo, Tamera J Corte, Yuben Moodley, et al.Respiratory Medicine|August 28, 2021
Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassayAdelle S Jee, Matthew J S Parker, Jane F Bleasel, et al.Respiration; International Review of Thoracic Diseases|April 19, 2021
Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features CohortAdelle S Jee, Matthew J S Parker, Jane F Bleasel, et al.Respiratory Medicine|February 14, 2024
Disease Behaviour Classification: A pragmatic model for predicting outcomes in Interstitial Lung DiseaseMegan Harrison, Helen E Jo, Lauren K Troy, et al.Respirology (Carlton, Vic.)|August 18, 2020
Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinicAnna E B McLean, Susanne E Webster, Margaret Fry, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 14, 2021
Quality of home spirometry performance amongst adults with cystic fibrosisJody M Bell, Sheila Sivam, Ruth L Dentice, et al.BMC Pulmonary Medicine|January 27, 2018
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registryHelen E Jo, Ian Glaspole, Yuben Moodley, et al.Pageof 3